Interferon Plus Ribavirin for Chronic Hepatitis C
Rebetron, a combination of injected recombinant interferon alfa-2b with oral ribavirin has been approved by the FDA for treatment of chronic hepatitis C virus infection....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Interferon Plus Ribavirin for Chronic Hepatitis C
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1054
Article Code: 1054b
Date: June 4, 1999
Volume: 41
Pages: 53-54
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1054
Article Code: 1054b
Date: June 4, 1999
Volume: 41
Pages: 53-54
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)